NEW YORK, March 26, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing first-in-class therapies for allergic and inflammatory diseases ...
NEW YORK - Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company with a market capitalization of $7.18 million, has announced the filing of amended claims with the U.S. Patent and ...
NEW YORK, March 26, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company focused on developing first-in-class therapies for allergic and inflammatory diseases, ...
TVGN Tevogen Bio Holdings Inc.
At close: 27 March at 4:00:02 pm GMT-4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback